Biology Reference
In-Depth Information
Koziel H, Kim S, Reardon C, Li X, Garland R, Pinkston P, Kornfeld H. 1999. Enhanced in vivo
HIV-1 replication in the lungs of HIV-infected persons with Pneumocystis carinii pneumonia.
Am J Resp Crit Care Med 160: 2048±2055.
Koziel H, Li X, Armstrong MYK, Richards FF, Rose RM. 2000. Alveolar macrophages from hu-
man immunode®ciency virus-infected persons demonstrate impaired oxidative burst response to
Pneumocystis carinii in vitro. Am J Resp Cell Mol Biol 23: 452±459.
Krishnan VL, Meager A, Mitchell DM, Pinching AJ. 1990. Alveolar macrophages in AIDS pa-
tients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii
pneumonia. Clin Exp Immunol 80: 156±160.
Kuo HP, Wang CH, Huang KS, Lin HC, Yu CT, Liu CY, Lu LC. 2000. Nitric oxide modulates
interleukin-1 beta and tumor necrosis factor-alpha synthesis by alveolar macrophages in pul-
monary tuberculosis. Am J Respir Crit Care Med 161: 192±199.
Kypr J, Mrazek J, Reich J. 1989. Nucleotide composition bias and CpG dinucleotide content in the
genomes of HIV and HTLV 1/2. Biochim Biophys Acta 1009: 280±282.
Lane BR, Markovitz DM, Woodford NL, Rochford R, Streiter RM, Co¨ey MJ. 1999. TNF-alpha
inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing
the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J
Immunol 163: 3653±3661.
Lebargy F, Branellec A, Deforges L, Bignon J, Bernaudin J-F. 1994. HIV-1 in human alveolar
macrophages from infected patients is latent in vivo but replicates after in vitro stimulation. Am
J Cell Mol Biol 10: 72±78.
Lohmann-Matthes ML, Steinmuller C, Franke-Ullmann G. 1994. Pulmonary macrophages. Eur
Respir J 7: 1678±1689.
Luster AD, Ravetch JV. 1987. Biochemical characterization of a gamma interferon-inducible cyto-
kine. (IP-10). J Exp Med 166: 1084±1097.
Marques LJ, Teschler H, Guzman J, Costabel U. 1997. Smoker's lung transplanted to a nonsmoker.
Am J Respir Crit Care Med 156: 1700±1702.
Mathys JM, Melanson SM, Schi¨er-Alberts DJ, Ioannidis JPA, Koziel H, Skolnik PR. 2000.
NF-kB modulates TNF-alpha production by alveolar macrophages in asymptomatic HIV-
seropositive individuals. J Immunol 164: 1588±1594.
Millar A, Miller R, Foley N, Meager A, Semple S, Rook G. 1991. Production of tumor necrosis
factor-alpha by blood and lung mononuclear phagocytes from patients with human immuno-
de®ciency virus-related lung disease. Am J Respir Cell Mol Biol 5: 144±148.
Murray HW, Gellene RA, Libby DM, Rothermel CD, Rubin BY. 1985. Activation of tissue mac-
rophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines
and interferon-gamma. J Immunol 135: 2374±2377.
Musher DM, Watson DA, Nickerson D, Gyorkey F, Lahart C, Rossen RD. 1990. The e¨ect of
HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary
alveolar macrophages. Am J Med Sci 299: 158±163.
Nakata K, Weiden M, Harkin T, Ho D, Rom WN. 1995. Low copy number and limited variability
of proviral DNA in alveolar macrophages from HIV-1 infected patients: evidence for genetic
di¨erences in HIV-1 between lung and blood macrophage populations. Mol Med 1: 744±757.
Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, Weiden M. 1997. Mycobacte-
rium tuberculosis enhances human immunode®ciency virus-1 replication in the lung. Am J Respir
Crit Care Med 155: 996±1003.
Nathan C. 1987. Macrophage secretion. J Clin Invest 79: 319±326.
Orosi P, Nugent K. 1993. Studies of phagocytic and killing activities of alveolar macrophages in
patients with sarcoidosis. Lung 171: 225±233.
Palecanda A, Paulauskis J, Al-Mutairi E, Imrich A, Qin G, Suzuki H, Kodama T, Tryggvason K,
Koziel H, Kobzik L. 1999. Role of the scavenger receptor MARCO in alveolar macrophage
binding of unopsonized environmental particles. J Exp Med 189: 1497±1506.
